Diagnostic Industry - Angel Broking

Mr. Keshav Lahoti - Associate Equity Analyst, Angel Broking Ltd

"Diagnostic industry business has increased compared to the pre-covid scenario as the novel virus related testing is an additional source of revenue for them. According to a business update released by the Companies, Thyrocare and Metropolis Healthcare revenue have increased by ~37% and ~25% for Q2FY21 compared to the same quarter of the last year. For the month of September, Metropolis Healthcare revenue jumped by ~40% and the Company also achieved normalcy in non-covid business for the month. Fortis Healthcare owned SRL recently highlighted that their non-covid business are almost back to normal. About 25% of their revenue comes from covid related business. We expect a similar set of numbers from Dr Lal Pathlabs. We are positive on the industry and expect a strong set of numbers in the upcoming quarters. Metropolis Healthcare is our preferred pick from the sector."

Source : Equity Bulls

Keywords